The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
After finishing at $8.5 in the prior trading day, RxSight Inc (NASDAQ: RXST) closed at $8.55, up 0.59%. In other words, the price has increased by $0.59 from its previous closing price. On the day, 0.89 million shares were traded. RXST stock price reached its highest trading level at $8.63 during the session, while it also had its lowest trading level at $8.46.
Ratios:
Our goal is to gain a better understanding of RXST by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 12.70 and its Current Ratio is at 13.93. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.04.
Wells Fargo Downgraded its Overweight to Equal Weight on July 09, 2025, while the target price for the stock was maintained at $9.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 12 ’25 when Fountain Tamara sold 7,000 shares for $25.71 per share. The transaction valued at 180,002 led to the insider holds 24,793 shares of the business.
TAMARA R FOUNTAIN bought 7,000 shares of RXST for $180,002 on Mar 12 ’25. On Jan 22 ’25, another insider, Maniar Shweta, who serves as the Director of the company, sold 3,519 shares for $30.87 each. As a result, the insider received 108,618 and left with 7,383 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RXST now has a Market Capitalization of 349831808 and an Enterprise Value of 134055480. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.38 while its Price-to-Book (P/B) ratio in mrq is 1.26. Its current Enterprise Value per Revenue stands at 0.912 whereas that against EBITDA is -3.409.
Stock Price History:
The Beta on a monthly basis for RXST is 1.16, which has changed by -0.8458626 over the last 52 weeks, in comparison to a change of 0.1590569 over the same period for the S&P500. Over the past 52 weeks, RXST has reached a high of $57.53, while it has fallen to a 52-week low of $6.32. The 50-Day Moving Average of the stock is -9.16%, while the 200-Day Moving Average is calculated to be -62.82%.
Shares Statistics:
The stock has traded on average 1.31M shares per day over the past 3-months and 1206940 shares per day over the last 10 days, according to various share statistics. A total of 40.91M shares are outstanding, with a floating share count of 37.48M. Insiders hold about 8.40% of the company’s shares, while institutions hold 94.01% stake in the company. Shares short for RXST as of 1755216000 were 5774428 with a Short Ratio of 4.41, compared to 1752537600 on 4955772. Therefore, it implies a Short% of Shares Outstanding of 5774428 and a Short% of Float of 14.81.
Earnings Estimates
A comprehensive evaluation of RxSight Inc (RXST) is underway, with the input of 6.0 analysts contributing to its current rating.The consensus estimate for the next quarter is -$0.21, with high estimates of -$0.06 and low estimates of -$0.39.
Analysts are recommending an EPS of between -$0.43 and -$0.89 for the fiscal current year, implying an average EPS of -$0.58. EPS for the following year is -$0.58, with 6.0 analysts recommending between -$0.19 and -$1.13.
Revenue Estimates
10 analysts predict $25.63M in revenue for the current quarter. It ranges from a high estimate of $28.8M to a low estimate of $24.6M. As of the current estimate, RxSight Inc’s year-ago sales were $35.31MFor the next quarter, 10 analysts are estimating revenue of $28.63M. There is a high estimate of $29.8M for the next quarter, whereas the lowest estimate is $27.4M.
A total of 11 analysts have provided revenue estimates for RXST’s current fiscal year. The highest revenue estimate was $129.5M, while the lowest revenue estimate was $125M, resulting in an average revenue estimate of $125.86M. In the same quarter a year ago, actual revenue was $139.93MBased on 11 analysts’ estimates, the company’s revenue will be $134.29M in the next fiscal year. The high estimate is $142.5M and the low estimate is $122.7M.
